Research Network Operator and Evidence Generator
Graticule’s global, scalable, and adaptable real-world data solutions overcome complex research challenges to swiftly and effectively conduct studies.
Research Network Operator and Evidence Generator
Graticule’s global, scalable, and adaptable real-world data solutions overcome complex research challenges to swiftly and effectively conduct studies.
We advance medical innovation through intelligent use of real-world data.
By collaborating with health systems and data aggregators to harness the power of EHR data, we provide life science leaders with the ability to navigate complex challenges in global data sourcing, research planning, and study execution. Our focus on real-world evidence helps clients position their products for commercial success.
Real-World Evidence Capabilities
Data Licensing
Global Network Building
Data Feasibility/Landscaping
Insights from EHR Data (structured/unstructured)
Clinical Development Support
Study Planning and Execution
Clinical Capabilities
eSourcing
Patient Identification/Trial Recruitment
Solutions to Power Impactful Research
Leadership
Our team of cross functional experts includes data scientists, epidemiologists, clinical researchers, and software developers. Founded in 2019 by Dan Poscover and Dan Housman, our leadership team consists of established veterans and innovators.
Dan Poscover
CEO
Dan, co-founder of Graticule, is a renowned strategic advisor to life science companies, medical device organizations, and health systems. At Gratiule, Dan works closely with our international client base to optimize use of data, analytics and real-world evidence to advance personalized medicine and improve population health around the globe. Previously, Dan was EVP of Strategy and Partnering at PatientsLikeMe.Dan Housman
CTO
Dan, co-founder of Graticule, is a respected entrepreneur known for launching successful startups centered on using patient data to transform research and care delivery. As Graticule’s Chief Technology Officer, he leads our development of data and analytics solutions to help life sciences companies advance research efficiency and quality and successfully bring products to market. Dan is also the CEO of an early-stage pre-clinical startup developing peptide therapeutics aimed at boosting GLP-1 effectiveness for obesity and exploring novel targets for anorexia.Partnerships
Strategic partnerships in data and analytics bolster our support so we can help overcome your unique challenges.
Strategic Partnerships
Health System Partnerships